Sbi Securities Co., Ltd. Cognition Therapeutics Inc Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 401 shares of CGTX stock, worth $709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
401
Previous 401
-0.0%
Holding current value
$709
Previous $169,000
26.63%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
16.3MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$10.6 Million2.56% of portfolio
-
Davenport & CO LLC2.69MShares$4.76 Million0.02% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$2.31 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA702KShares$1.24 Million0.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $40.2M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...